Loading news...
Shares of Valhi, Inc. (NYSE: VHI - Get Free Report) passed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $12.81 and traded as high as $15.02. Valhi shares last traded at $14.7950, with a volume of 32,930 shares changing hands. Wall Street Analyst Weigh
Valhi (NYSE: VHI - Get Free Report) and Albemarle (NYSE: ALB - Get Free Report) are both basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Risk and Volatility Valhi has a beta of 1.18,
Valhi (NYSE: VHI - Get Free Report) and Asahi Kasei (OTCMKTS:AHKSY - Get Free Report) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Analyst Ratings This is a summary of recent
Valhi, Inc. (NYSE: VHI - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $15.31 and traded as low as $11.65. Valhi shares last traded at $11.88, with a volume of 10,027 shares. Wall Street Analyst Weigh
Vitalhub Corp. (TSE: VHI - Get Free Report) was up 0.7% during trading on Tuesday. The company traded as high as C$9.20 and last traded at C$9.14. Approximately 388,970 shares changed hands during mid-day trading, an increase of 145% from the average daily volume of 158,735 shares. The stock had previously closed at C$9.08. Wall
Valhi (VHI) faces headwinds from lower TiO2 prices and destocking on volumes, pressuring its chemical segment despite a positive perimeter effect from a joint venture buyout. Operating income declined due to falling TiO2 prices, stable input costs and general operating leverage on lower industrial volumes. A higher CAPEX commitment and weak market environment have reduced the NAV discount to just 4%.
Koppers (NYSE: KOP - Get Free Report) and Valhi (NYSE: VHI - Get Free Report) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Profitability This table compares Koppers and Valhi's net
Vitalhub Corp. ( VHI:CA ) Q3 2025 Earnings Call November 7, 2025 9:00 AM EST Company Participants Brian Goffenberg - CFO & Executive VP Daniel Matlow - President, CEO & Director Conference Call Participants Gavin Fairweather - Cormark Securities Inc., Research Division Doug Taylor - Canaccord Genuity Corp., Research Division David Kwan - TD Cowen, Research Division Richard Tse - National Bank Financial, Inc., Research Division John Shuter - RBC Capital Markets, Research Division Michael Freeman - Raymond James Ltd., Research Division Kevin Krishnaratne - Scotiabank Global Banking and Markets, Research Division Presentation Unknown Executive Hi.
Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported a net loss attributable to Valhi stockholders of $22.2 million, or $.78 per share, in the third quarter of 2025 compared to net income of $57.5 million, or $2.01 per share, in the third quarter of 2024. For the first nine months of 2025, Valhi reported a net loss attributable to Valhi stockholders of $4.4 million, or $.15 per share, compared to net income of $85.2 million, or $2.99 per share, in the first nine months of 2024. Net income attributable to Valhi stockholders decreased in the third quarter and first nine months of 2025 as compared to the same periods in 2024 primarily due to lower operating results from the Chemicals Segment, a third quarter non-cash gain in 2024 related to the Chemicals Segment acquisition of the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) discussed below and an increase in the Company's tax expense due to legislation enacted in Germany during the third quarter of 2025, which resulted in a non-cash deferred income tax expense of $19.3 million ($12.8 million, or $.45 per share, net of noncontrolling interest).
Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on December 18, 2025 to stockholders of record at the close of business on November 21, 2025.
Dallas, Texas, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that, subject to the completion of quarter-end closing procedures, it expects to report third quarter 2025 earnings in a press release after market close on Thursday, November 6, 2025.
TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced that Novari Health (“Novari”), a VitalHub company, has been commissioned for its first UK deployment with the South West Provider Collaborative for its electronic referral and bed management workflow solution. The deployment will expand Novari's geographic footprint beyond current implementations in Canada and Australia.
TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it has changed its auditor from MNP LLP (the “Former Auditor”) to Ernst & Young LLP (the “Successor Auditor”) effective September 9, 2025.
Toronto, Ontario--(Newsfile Corp. - September 9, 2025) - Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") announced today that it has been included in the TSX30 for 2025. The Company ranked 18 on the list of top 30 performing stocks on Toronto Stock Exchange, with a dividend-adjusted share price appreciation of 310% over the course of the last three years, which correlates to a 429% increase in market capitalization over the same time period.
Toronto, Ontario--(Newsfile Corp. - August 20, 2025) - Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is pleased to announce that it has closed its previously announced bought deal offering pursuant to a press release dated August 15, 2025. A total of 5,885,828 common shares of VitalHub (the "Common Shares") were sold at a price of $12.70 per Common Share for total gross proceeds of approximately $74.75 million, which included the full exercise of the over-allotment option (the "Offering").
The Base Shelf Prospectus and the Prospectus Supplement will be accessible through SEDAR+ Toronto, Ontario--(Newsfile Corp. - August 15, 2025) - VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is pleased to announce that, in connection with its previously announced "bought deal" public offering, it has filed a prospectus supplement dated August 15, 2025 (the "Prospectus Supplement") to the Company's base shelf prospectus dated July 23, 2025 (the "Base Shelf Prospectus") with the securities commissions in each of the provinces of Alberta, British Columbia and Ontario, to qualify the distribution of 5,118,111 common shares from the treasury of the Company (the "Common Shares") at a price of $12.70 per Common Share (the "Offering Price") for aggregate gross proceeds of approximately $65 million, and up to an additional 767,717 Common Shares which may be issued upon exercise of an over-allotment option, for additional gross proceeds, if exercised, of approximately $9,750,000, the particulars of which are further described in the Prospectus Supplement (the "Offering"). Cormark Securities Inc. and National Bank Financial Inc. are acting as co-lead underwriters, on behalf of a syndicate of underwriters in connection with the Offering.
Valhi (VHI) Q2 EPS Drops 96%
Dallas, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on September 25, 2025 to stockholders of record at the close of business on September 5, 2025.
Dallas, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $.9 million, or $.03 per share, in the second quarter of 2025 compared to $19.9 million, or $.70 per share, in the second quarter of 2024. For the first six months of 2025, Valhi reported net income attributable to Valhi stockholders of $17.8 million, or $.62 per share, compared to $27.7 million, or $.97 per share, in the first six months of 2024. Net income attributable to Valhi stockholders decreased in the second quarter of 2025 as compared to the same period of 2024 primarily due to lower operating results from the Chemicals Segment partially offset by higher operating results from the Real Estate Management and Development Segment. Net income attributable to Valhi stockholders decreased in the first six months of 2025 as compared to the same period of 2024 primarily due to lower operating results from the Chemicals Segment partially offset by higher operating results from the Component Products and Real Estate Management and Development Segments. As previously reported, effective July 16, 2024, the Chemicals Segment acquired the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) previously held by Venator Investments, Ltd. Prior to the acquisition, the Chemicals Segment held a 50% joint venture interest in LPC. Following the acquisition, LPC became a wholly-owned subsidiary of the Chemicals Segment. We accounted for the acquisition as a business combination. The results of operations of LPC have been included in our results of operations beginning as of the acquisition date.
Valhi's NAV discount is present and may be bigger than what we've put, but broadly, it doesn't look like it is beyond the norm for a holding company. On top of that, markets have reacted to Tronox having a pressured quarter, despite measures like anti-dumping against China protecting some markets. Valhi and constituent Kronos shares have been appropriately punished by the Tronox leading indication. Moreover, we don't see an upward inflection coming in end markets based on macro.